Nature

Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer

This open-label study evaluated the efficacy and safety of a new leuprolide acetate 45 mg 6-month depot formulation in 151 men with prostate cancer who received 2 intramuscular injections administered ...
ascopubs.org

Onset and maintenance of testosterone suppression in four pivotal trials of subcutaneously administered leuprolide acetate formulated with in-situ forming polymeric delivery ...

Nadir testosterone (T) following in-situ polymer delivered, subcutaneously administered leuprolide acetate in men with prostate cancer (PCa). Clinical experience with 100 consecutive patients treated ...
Nature

Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels

Endocrine therapy is the most frequently employed treatment for prostate cancer, and luteinizing hormone releasing hormone (LH-RH) agonists alone or in combination with anti-androgen agents are ...
Business Insider

Data on Nadir Testosterone Levels Achieved by ELIGARD® (leuprolide acetate) for injectable suspension published in Reviews in Urology

CHICAGO, July 24, 2019 (GLOBE NEWSWIRE) -- Tolmar Pharmaceuticals, Inc. today announced the publication of a study of nadir testosterone (T) levels achieved in pivotal trials for ELIGARD ® (leuprolide ...